Scott M. Coiante, SVP, Chief Financial Officer at Aprea Therapeutics, Inc. (APRE), bought 2,500 shares at $15.00 ($38K) on 2019-10-07, disclosed to the SEC on 2019-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.